Magdalena Janczewska

Algemeen Directeur bij NanoThea SA

Health Technology

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Tomasz Adam Ciach	M	58	NanoThea SA NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.	12 jaar
Marek Borzestowski	M	52	NanoThea SA NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.	-
Piotr Wojciech Pietrzak	M	44	NanoThea SA NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.	9 jaar
Pawel Michal Ciach	M	56	NanoThea SA NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.	-
Kamil Kopec	M	-	NanoThea SA NanoThea SA BiotechnologyHealth Technology NanoThea SA develops radiopharmaceuticals for neoplastic diseases. It provides PET diagnosis and treatment of patients with metastatic tumours. The company was founded by Tomasz Ciach and Magdalena Janczewska in 2012 and is headquartered in Warsaw, Poland.	-